UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv52-iv61

2017

Volltextzugriff (PDF)

IMWG consensus on risk stratification in multiple myeloma

Leukemia, 2014-02, Vol.28 (2), p.269-277

2014

Volltextzugriff (PDF)

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Leukemia, 2009-12, Vol.23 (12), p.2210-2221

2009

Volltextzugriff (PDF)

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Leukemia, 2018-04, Vol.32 (4), p.1043-1047

2018

Volltextzugriff (PDF)

Progestin-associated shift of meningioma mutational landscape

Annals of oncology, 2018-03, Vol.29 (3), p.681-686

2018

Volltextzugriff (PDF)

Epidemiology of meningiomas

Neuro-chirurgie, 2018-03, Vol.64 (1), p.5-14

2018

Volltextzugriff (PDF)

Second Impact Syndrome. Myth or reality?

Neuro-chirurgie, 2021-05, Vol.67 (3), p.265-275

2021

Volltextzugriff (PDF)

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Leukemia, 2018-01, Vol.32 (1), p.111-119

2018

Volltextzugriff (PDF)

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

Leukemia, 2013-03, Vol.27 (3), p.711-717

2013

Volltextzugriff (PDF)

Molecular and clinical diversity in primary central nervous system lymphoma

Annals of oncology, 2023-02, Vol.34 (2), p.186-199

2023

Volltextzugriff (PDF)

Expressed fusion gene landscape and its impact in multiple myeloma

Nature communications, 2017-12, Vol.8 (1), p.1893-10, Article 1893

2017

Volltextzugriff (PDF)

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients

Leukemia, 2013-01, Vol.27 (1), p.202-207

2013

Volltextzugriff (PDF)

Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and ‘retreatment’ approaches in the era of novel agents

Leukemia, 2012-01, Vol.26 (1), p.73-85

2012

Volltextzugriff (PDF)

Management of treatment-emergent peripheral neuropathy in multiple myeloma

Leukemia, 2012-04, Vol.26 (4), p.595-608

2012

Volltextzugriff (PDF)

Gene signature combinations improve prognostic stratification of multiple myeloma patients

Leukemia, 2016-05, Vol.30 (5), p.1071-1078

2016

Volltextzugriff (PDF)

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients

Leukemia, 2018-02, Vol.32 (2), p.376-382

2018

Volltextzugriff (PDF)

Minor clone provides a reservoir for relapse in multiple myeloma

Leukemia, 2013-02, Vol.27 (2), p.473-481

2013

Volltextzugriff (PDF)

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e467-e467

2016

Volltextzugriff (PDF)

Prospective longitudinal study on the evolution of autobiographical memory in patients irradiated for benign skull base tumour

Cancer radiothérapie, 2024-08, Vol.28 (4), p.309

2024

Volltextzugriff (PDF)

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

Haematologica (Roma), 2010-11, Vol.95 (11), p.1973-1976

2010

Volltextzugriff (PDF)

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

Leukemia, 2014-05, Vol.28 (5), p.1129-1131

2014

Volltextzugriff (PDF)

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

Leukemia, 2010-03, Vol.24 (3), p.623-628

2010

Volltextzugriff (PDF)

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

Journal of neuro-oncology, 2021, Vol.151 (2), p.279-286

2021

Volltextzugriff (PDF)

Next Generation Sequencing for Minimal Residual Disease

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e6-e6

Avet-Loiseau, H

2015

Volltextzugriff (PDF)

1 – 25 von 809

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(714)
Mit Volltextzugriff
(643)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(428)
Humans
(327)
Life Sciences & Biomedicine
(323)
Female
(164)
Male
(161)
Biological And Medical Sciences
(154)
Medical Sciences
(143)
Hematology
(127)
Adult
(112)
Oncology
(109)
Middle Aged
(107)
Aged
(94)
Physical Sciences
(86)
Life Sciences
(85)
Prognosis
(70)
Physics
(67)
Multiple Myeloma
(63)
Neurosciences & Neurology
(63)
Hematologic And Hematopoietic Diseases
(59)
Multiple Myeloma - Genetics
(59)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

IMWG consensus on risk stratification in multiple myeloma

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Progestin-associated shift of meningioma mutational landscape

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

Epidemiology of meningiomas

Second Impact Syndrome. Myth or reality?

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

Molecular and clinical diversity in primary central nervous system lymphoma

Expressed fusion gene landscape and its impact in multiple myeloma

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients

Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and ‘retreatment’ approaches in the era of novel agents

Management of treatment-emergent peripheral neuropathy in multiple myeloma

Gene signature combinations improve prognostic stratification of multiple myeloma patients

Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients

Minor clone provides a reservoir for relapse in multiple myeloma

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Prospective longitudinal study on the evolution of autobiographical memory in patients irradiated for benign skull base tumour

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

Next Generation Sequencing for Minimal Residual Disease

Suchergebnisse filtern